Health Care·Health Care Distributors·$101.3B
McKesson Corp is a leading health care distributor that plays a crucial role in the supply chain by delivering pharmaceuticals and medical supplies to health care providers. With a market cap of $103 billion, the company is positioned in the health care sector, which is increasingly focused on efficiency and cost management as demand for health services continues to rise.
Earnings Per Share (EPS)
EPS is a key indicator of profitability and will show how well McKesson is managing costs and generating income.
Revenue Growth
Revenue growth will provide insight into how effectively McKesson is expanding its market presence amid changing health care demands.
1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.
McKesson Corp is a leading health care distributor that plays a crucial role in the supply chain by delivering pharmaceuticals and medical supplies to health care providers. With a market cap of $103 billion, the company is positioned in the health care sector, which is increasingly focused on efficiency and cost management as demand for health services continues to rise.
EPS Beat Streak
2Q
EPS Beat Rate
63%
Avg EPS Surprise
+2.81%
Avg Stock Reaction
-0.05%
In the last quarter (Q3-2026), McKesson reported an EPS of $9.34, slightly beating expectations. However, the stock fell 3.42% the following day, indicating mixed investor sentiment.
Management Promises & Guidance
Overall, expectations for McKesson are cautious, with analysts looking for signs of sustained profitability and revenue growth. Investors are particularly focused on how the company navigates current market challenges.
Bull Case
The optimistic view hinges on McKesson delivering strong EPS growth and demonstrating robust revenue expansion, which could lead to increased investor confidence and a positive stock reaction.
Bear Case
Conversely, if McKesson fails to meet earnings expectations or shows signs of declining margins, it could lead to a significant drop in stock price, reflecting investor concerns about the company's future performance.
Earnings Per Share (EPS)
N/AEPS is a key indicator of profitability and will show how well McKesson is managing costs and generating income.
Revenue Growth
N/ARevenue growth will provide insight into how effectively McKesson is expanding its market presence amid changing health care demands.
Operating Margin
N/AOperating margin reflects the efficiency of McKesson's operations, which is critical in a competitive market.
The print will turn on these two things.
Q1
What is the projected EPS for Q4-2026?
EPS is a critical measure of profitability, and a strong figure could boost investor confidence, while a weak number could raise concerns.
Q2
How is McKesson addressing supply chain challenges?
With ongoing disruptions in the supply chain, insights into McKesson's strategies will be vital for understanding its operational resilience.
Why consensus could be wrong
The Street may be underestimating McKesson's ability to navigate supply chain challenges effectively, leading to stronger-than-expected EPS.
Supporting Evidence
Recent operational improvements may not be fully reflected in current EPS estimates.
Options pricing suggests a significant move, indicating that investors expect surprises.
Historical performance shows that McKesson often rebounds after initial negative reactions.
Key Risk
If the EPS exceeds $9.50, it could challenge the current bearish sentiment and shift investor expectations.
Pre-commit to what would confirm each case.
This quarter's performance will be closely scrutinized as investors weigh the company's ability to maintain margins amid rising costs and market pressures.
Bull Confirmed If
An EPS of $9.50 or higher would confirm the bull case, indicating strong profitability.
Bear Confirmed If
An EPS below $8.75 would signal significant concerns about McKesson's profitability and operational efficiency.
Implied Move
±5.41%
Historical Avg
±2.1%
The options market is pricing in a relatively large move, suggesting that investors are anticipating significant volatility around the earnings report.
Options are pricing ±5.4% while MCK has averaged ±2.1% over the last 8 prints — setup is pricing rich.
Likely market behavior by outcome — not investment advice.
Beat & Raise
If McKesson beats expectations, history suggests the stock could see a modest positive reaction, confirming strong operational performance.
In-Line / Cautious
If results are in line with expectations but management provides cautious commentary, the stock may remain volatile as investors reassess future growth.
Miss
A miss on earnings could lead to a decline in stock price, with history indicating an average drop of around 0.70% following such outcomes.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
PARAMOUNT SKYDANCE C Class B
May 4, 2026